Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More
Generative AI has become a key piece of infrastructure in many industries, and healthcare is no exception. Yet, as organizations like GSK push the boundaries of what generative AI can achieve, they face significant challenges — particularly when it comes to reliability. Hallucinations, or when AI models generate incorrect or fabricated information, are a…
Article Source https://venturebeat.com/ai/hallucinations-in-ai-how-gsk-is-addressing-a-critical-problem-in-drug-development/
